Cambridge spin-out PharmEnable raises £1.8m for drug discovery
The funds will enable in-house drug discovery across a number of therapeutic areas including cancer and neurodegeneration
Read More
Tag: Cambridge Enterprise
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
